medigraphic.com
Colegio de Medicina Interna de México.

2007, Number 5

<< Back Next >>

Med Int Mex 2007; 23 (5)

Metanolic lack of control associated with depression under Beck depression inventory in recent diagnosed type 2 diabetic patients

Escobedo LC, Díaz GNA, Lozano NJJ, Rubio GAF, Varela GG

Language: Spanish
References: 21
Page: 385-390
PDF size: 243.70 Kb.


ABSTRACT

Background: Recent studies of prevalency suggest that 15% of the diabetics suffers clinical depression and near 30% of some other psychiatric dysfunction. Controversy exists about the relationship between the depression and the glycaemic control, but until the moment there is no a conclusive study in this respect.
Objective: To determine the depression grade and their association with the metabolic control in recent diagnosed type 2 diabetic patients of the Hospital General de Ticoman.
Material and methods: We carry out an analytic cross-sectional study in the external consultation of Internal Medicine, of the Hospital General de Ticoman, including 46 recent diagnosed type 2 diabetic patients, of both gender that will have plasmatic fast glucose of not more than a month of determination, without including those with another chronic illness degenerative different to type 2 diabetes mellitus, acute or chronic complications of the same one, antidepressive treatment, or neuropsychiatric illness concomitant, as well as illiterate. It foresaw informed consent a Beck Depression Inventory was granted for their self-test.
Results: The sample consisted on 11 men (24%) and 35 women (76%) with ages between 33 and 78 years (mean 51 ± 11 years). According to the result in the Beck Depression Inventory were divided in four groups: patient without depression (8), patient with mild depression (20), moderate (14) and severe (4), observing the following values of plasmatic fast glucose for the group without depression was 223 ± 53, mild depression group 195 ± 44, moderate depression group 297 ± 37 and severe depression group 406 ± 41. ANOVA was applied for the intergrupal comparison between the depression grade and the levels of plasmatic fast glucose, obtaining a p = 0.0001.
Conclusions: Association exists between the depression grade and the hyperglycaemia, observing growing values of glycaemia when increasing the depression grade.


REFERENCES

  1. Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 2005;118(9):939-47.

  2. Aguilar CA, Reyes E, Ordoñez ML, Torres MA, et al. Early-onset type 2 diabetes: metabolic and genetic characterization in the Mexican population. J Clin Endocrinol Metab 2001;86(1):220-6.

  3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29:S43-S48.

  4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes. Lancet 1998;352:837-53.

  5. Nathan DM, Buse JB, Davidson MB, Heine RJ, et al. Management of hyperglucemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2006;29(8):1963-72.

  6. Vileikyte L, Leventhal H, Gonzalez JS, Peyrot M, et al. Diabetic peripheral neuropathy and depressive symptoms. Diabetes Care 2005;28(10):2378-83.

  7. Lane JD, McCaskill CC, Williams PG, Parekh PI, et al. Personality correlates of glycemic control in type 2 diabetes. Diabetes Care 2000;23(9):1321-5.

  8. Lin EHB, Katon W, Von Korff M, Rutter C, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004;27(9):2154-60.

  9. Geffken GR, Ward HE, Staub JP, Carmichael S, Evans D. Psychiatric morbidity in endocrine disorders. Psychiatr Clin North Am 1998;21(2):473-89.

  10. Jacobson D. Psychiatric secrets. 2nd ed. Henley and Belfus, 2001

  11. Grissom GR, Phillips RA. Screening for depression. Arch Intern Med 2005;163:1214-6.

  12. Engum A, Mykletum A, Midthjell K, Holen A, Dahl AA. Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care 2005;28(8):1904-9.

  13. Nichols GA, Brown JB. Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care 2003;26(3):744-9.

  14. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24(6):1069-78.

  15. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican-Americans with type 2 diabetes. Diabetes Care 2003;26(10):2822-8.

  16. Finkelstein EA, Bray JW, Chen H, Chen H, et al. Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 2003;26(2):415-20.

  17. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002;25(3):464-70.

  18. De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63(4):619-30.

  19. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function and costs. Arch Intern Med 2000;160(21):3278-85.

  20. Ciechanowsky PS, Katon WJ, Russo JE, Hirsch I. The relationship of depressive symptoms to symptom reporting, self care and glucose control in diabetes. Gen Hosp Psychiatry 2003;25(4):246-52.

  21. Brown LC, Majumdar SR, Newman SC, Johnson JA. Type 2 diabetes does not increase risk of depression. CMAJ 2006;175(1).




2020     |     www.medigraphic.com